Vincenzo Bove
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vincenzo Bove has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Ivo Boškoski
Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
20 shared publications - Guido Costamagna
Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
14 shared publications - Maria Valeria Matteo
Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
10 shared publications - Cristiano Spada
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
8 shared publications - Andrea Tringali
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Lazio, Italy
6 shared publications - Giorgio Carlino
CEMAD Centro Malattie dell’Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy
6 shared publications
Latest Publications
- Open Access
- 8 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2832
Endoscopy for Metabolic Diseases
Endoscopic bariatric and metabolic therapies (EBMTs) offer minimally invasive treatment options for obesity and related metabolic disorders such as type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD). These therapies are broadly categorized into gastric and small bowel interventions. Gastric EBMTs, including intragastric balloons and endoscopic sleeve gastroplasty, promote weight loss primarily through mechanical restriction and delayed gastric emptying, thereby improving metabolic outcomes. Small bowel therapies target the proximal intestine to modulate nutrient-sensing and hormonal pathways, providing metabolic benefits that may occur independently of weight loss. Techniques such as duodenal mucosal resurfacing, electroporation-based re-cellularization, and duodenal-jejunal bypass liners demonstrate promising effects on glycemic control, insulin sensitivity, and liver health. Emerging technologies utilizing thermal, vapor, and laser ablation further expand therapeutic possibilities. While these interventions show favorable safety profiles and potential as standalone or adjunctive treatments, further long-term studies and randomized trials are necessary to optimize patient selection and procedural protocols. Collectively, EBMTs represent an evolving paradigm in the management of obesity and metabolic diseases, bridging the gap between conservative medical therapies and bariatric surgery.
- 8 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2832
Open AccessEndoscopy for Metabolic Diseases
Endoscopic bariatric and metabolic therapies (EBMTs) offer minimally invasive treatment options for obesity and related metabolic disorders such as type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD). These therapies are broadly categorized into gastric and small bowel interventions. Gastric EBMTs, including intragastric balloons and endoscopic sleeve gastroplasty, promote weight loss primarily through mechanical restriction and delayed gastric emptying, thereby improving metabolic outcomes. Small bowel therapies target the proximal intestine to modulate nutrient-sensing and hormonal pathways, providing metabolic benefits that may occur independently of weight loss. Techniques such as duodenal mucosal resurfacing, electroporation-based re-cellularization, and duodenal-jejunal bypass liners demonstrate promising effects on glycemic control, insulin sensitivity, and liver health. Emerging technologies utilizing thermal, vapor, and laser ablation further expand therapeutic possibilities. While these interventions show favorable safety profiles and potential as standalone or adjunctive treatments, further long-term studies and randomized trials are necessary to optimize patient selection and procedural protocols. Collectively, EBMTs represent an evolving paradigm in the management of obesity and metabolic diseases, bridging the gap between conservative medical therapies and bariatric surgery.
- 3 October 2025
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 19 (10) , 1051-1061
How to deal with lower gastrointestinal defects: the role of endoscopy
Lower gastrointestinal (GI) defects, including leaks, perforations, and fistulas, pose significant challenges for diagnosis and management. These conditions are associated with high morbidity and mortality rates, necessitating effective treatment strategies to restore GI continuity and improve patient outcomes. This special report examines current evidence and future perspectives on the endoscopic management of lower GI defects. A literature search was conducted in PubMed, Google Scholar, and Scopus for studies published up to July 2025 that focused on the endoscopic management of lower GI defects. It provides an overview of various endoscopic techniques, including clips, endosuturing, stents, endoscopic internal drainage, endoscopic vacuum therapy, and emerging regenerative approaches, and their underlying advantages and limitations. The need for more standardized and larger studies to establish guidelines has been addressed. Endoscopy is increasingly being recognized as a therapeutic option for lower GI defects, offering less invasive alternatives to traditional surgery. The challenges in developing standardized protocols are due to diverse clinical scenarios and limited prospective data. Future advancements are expected in technologies and personalization of treatments. A multidisciplinary approach is essential to achieve optimal outcomes in this complex field.
- 3 October 2025
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 19 (10) , 1051-1061
How to deal with lower gastrointestinal defects: the role of endoscopy
Lower gastrointestinal (GI) defects, including leaks, perforations, and fistulas, pose significant challenges for diagnosis and management. These conditions are associated with high morbidity and mortality rates, necessitating effective treatment strategies to restore GI continuity and improve patient outcomes. This special report examines current evidence and future perspectives on the endoscopic management of lower GI defects. A literature search was conducted in PubMed, Google Scholar, and Scopus for studies published up to July 2025 that focused on the endoscopic management of lower GI defects. It provides an overview of various endoscopic techniques, including clips, endosuturing, stents, endoscopic internal drainage, endoscopic vacuum therapy, and emerging regenerative approaches, and their underlying advantages and limitations. The need for more standardized and larger studies to establish guidelines has been addressed. Endoscopy is increasingly being recognized as a therapeutic option for lower GI defects, offering less invasive alternatives to traditional surgery. The challenges in developing standardized protocols are due to diverse clinical scenarios and limited prospective data. Future advancements are expected in technologies and personalization of treatments. A multidisciplinary approach is essential to achieve optimal outcomes in this complex field.
- Open Access
- 30 November 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (6) , 711-724
The evolution and current state of bariatric endoscopy in Western countries
With the alarmingly increasing prevalence of obesity in the Western world, it has become necessary to provide more acceptable treatment options for patients with obesity. Minimally invasive endoscopic techniques are continuously evolving. Currently, metabolic and bariatric endoscopies encompass several different techniques that can offer significant weight loss and improvement in comorbidities with a favorable safety profile. Restrictive bariatric procedures include the use of intragastric balloons and gastric remodeling techniques with different suturing devices. Several studies have demonstrated the efficacy and safety of these techniques that are widely used in clinical practice. Small intestine-targeted metabolic endoscopy is an intriguing and rapidly evolving field of research, although it is not widespread in routine practice. These techniques include duodenal-jejunal bypass liners, duodenal mucosal resurfacing, and incisionless anastomoses. The aim of this review article is to provide a detailed update on the currently available bariatric endoscopy techniques in Western countries.
- 30 November 2024
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (6) , 711-724
Open AccessThe evolution and current state of bariatric endoscopy in Western countries
With the alarmingly increasing prevalence of obesity in the Western world, it has become necessary to provide more acceptable treatment options for patients with obesity. Minimally invasive endoscopic techniques are continuously evolving. Currently, metabolic and bariatric endoscopies encompass several different techniques that can offer significant weight loss and improvement in comorbidities with a favorable safety profile. Restrictive bariatric procedures include the use of intragastric balloons and gastric remodeling techniques with different suturing devices. Several studies have demonstrated the efficacy and safety of these techniques that are widely used in clinical practice. Small intestine-targeted metabolic endoscopy is an intriguing and rapidly evolving field of research, although it is not widespread in routine practice. These techniques include duodenal-jejunal bypass liners, duodenal mucosal resurfacing, and incisionless anastomoses. The aim of this review article is to provide a detailed update on the currently available bariatric endoscopy techniques in Western countries.
- 26 October 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (12) , 4573-4575
Impenetrable Abdomen: A Case Report of Endoscopic Sleeve Gastroplasty Performed in Patient with Huge Paramedian Laparocele
Introduction Bariatric surgical techniques have demonstrated scientific efficacy and interventional safety; however, these approaches are not universally appropriate for all patients. The term “impenetrable abdomen” refers to the inability to achieve surgical access to the abdominal cavity, a condition that may arise from several underlying factors. Endoscopic sleeve gastroplasty (ESG) is proposed as a safe and effective technique in this subgroup of patients with obesity. Materials and Methods A 56-year-old Caucasian woman with an impenetrable abdomen due to the presence of a large left paramedian laparocele underwent ESG (Fig. 1) to our unit. An abdominal computed tomography (CT) scan revealed a substantial laparocele in the left paramedian region, involving the tenuous loops, mesentery, and part of the transverse colon. The patient body mass index (BMI) at presentation was 47.15 kg/m2 (116 kg per 1.57 m). Comorbidities included obstructive sleep apnea syndrome (OSAS), requiring nocturnal continuous positive airway pressure (CPAP) therapy, hepatic steatosis, hypertension, hypertriglyceridemia, and hypovitaminosis D. The case was discussed with our multidisciplinary board team (MDT), who agreed to proceed with the ESG. The endoscopic procedure was performed in the supine position, using the Overstitch device and lasted 58 min. No intraprocedural or post-procedural complications/adverse events have been observed. The patient resumed a liquid diet on the first postoperative day and was discharged from the hospital 24 h after the procedure in good clinical condition. Results Regular outpatient follow-up visits showed significant reduction of the BMI at 6 months post-procedure with a value of 34.9 kg/m2 compared with the initial value of 47.1 kg/m2. Additionally, the patient’s use of nocturnal CPAP for OSAS was successfully discontinued suggesting an improvement in her respiratory condition as a result of weight loss. Moreover, there was a notable reduction in the pharmacological management required for arterial hypertension. These outcomes underscore the positive impact of selecting the most appropriate therapeutic strategy for each patient with obesity through a multidisciplinary team approach. Conclusion In our experience, we confirm that endoscopic sleeve gastroplasty is both feasible and safe in patients presenting with an impenetrable abdomen. Despite the minimally invasive approach, this technique has proven effective in terms of body weight loss and reduction of obesity related compared with bariatric surgery.
- 26 October 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (12) , 4573-4575
Impenetrable Abdomen: A Case Report of Endoscopic Sleeve Gastroplasty Performed in Patient with Huge Paramedian Laparocele
Introduction Bariatric surgical techniques have demonstrated scientific efficacy and interventional safety; however, these approaches are not universally appropriate for all patients. The term “impenetrable abdomen” refers to the inability to achieve surgical access to the abdominal cavity, a condition that may arise from several underlying factors. Endoscopic sleeve gastroplasty (ESG) is proposed as a safe and effective technique in this subgroup of patients with obesity. Materials and Methods A 56-year-old Caucasian woman with an impenetrable abdomen due to the presence of a large left paramedian laparocele underwent ESG (Fig. 1) to our unit. An abdominal computed tomography (CT) scan revealed a substantial laparocele in the left paramedian region, involving the tenuous loops, mesentery, and part of the transverse colon. The patient body mass index (BMI) at presentation was 47.15 kg/m2 (116 kg per 1.57 m). Comorbidities included obstructive sleep apnea syndrome (OSAS), requiring nocturnal continuous positive airway pressure (CPAP) therapy, hepatic steatosis, hypertension, hypertriglyceridemia, and hypovitaminosis D. The case was discussed with our multidisciplinary board team (MDT), who agreed to proceed with the ESG. The endoscopic procedure was performed in the supine position, using the Overstitch device and lasted 58 min. No intraprocedural or post-procedural complications/adverse events have been observed. The patient resumed a liquid diet on the first postoperative day and was discharged from the hospital 24 h after the procedure in good clinical condition. Results Regular outpatient follow-up visits showed significant reduction of the BMI at 6 months post-procedure with a value of 34.9 kg/m2 compared with the initial value of 47.1 kg/m2. Additionally, the patient’s use of nocturnal CPAP for OSAS was successfully discontinued suggesting an improvement in her respiratory condition as a result of weight loss. Moreover, there was a notable reduction in the pharmacological management required for arterial hypertension. These outcomes underscore the positive impact of selecting the most appropriate therapeutic strategy for each patient with obesity through a multidisciplinary team approach. Conclusion In our experience, we confirm that endoscopic sleeve gastroplasty is both feasible and safe in patients presenting with an impenetrable abdomen. Despite the minimally invasive approach, this technique has proven effective in terms of body weight loss and reduction of obesity related compared with bariatric surgery.
- 9 June 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (6) , AB39
2-YEARS OUTCOME OF TRANSORAL OUTLET REDUCTION FOR DUMPING SYNDROME AND WEIGHT REGAIN AFTER ROUX-EN-Y GASTRIC BYPASS
- 9 June 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 97 (6) , AB39
2-YEARS OUTCOME OF TRANSORAL OUTLET REDUCTION FOR DUMPING SYNDROME AND WEIGHT REGAIN AFTER ROUX-EN-Y GASTRIC BYPASS
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S275
Mistake during endoscopic snare papillectomy
Text A 74 year-old lady underwent endoscopic papillectomy. At the end of en-bloc resection severe bleeding occurred. A 25-gauge needle was advanced to perform a submucosal injection of diluted epinephrine (1:10000). The presence of abundant amount of blood in the duodenum reduced the visibility and an excessive pression on the needle tip led to duodenal wall perforation. Two 16 mm endoclips were placed and promptly closed the duodenal wall defect. The patient was referred for urgent CT scan, confirming the presence of free air in the retroperitoneum. After 7 days a control CT scan showed reduction of the retropeumoperitoneum without collections. Clinical course was uneventful. The patient is free of recurrence after 2 year. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S275
Mistake during endoscopic snare papillectomy
Text A 74 year-old lady underwent endoscopic papillectomy. At the end of en-bloc resection severe bleeding occurred. A 25-gauge needle was advanced to perform a submucosal injection of diluted epinephrine (1:10000). The presence of abundant amount of blood in the duodenum reduced the visibility and an excessive pression on the needle tip led to duodenal wall perforation. Two 16 mm endoclips were placed and promptly closed the duodenal wall defect. The patient was referred for urgent CT scan, confirming the presence of free air in the retroperitoneum. After 7 days a control CT scan showed reduction of the retropeumoperitoneum without collections. Clinical course was uneventful. The patient is free of recurrence after 2 year. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S265-S266
Redo Transoral Outlet Reduction (Re-TORe): technical feasibility and medium-term outcomes
Aims Weight regain and dumping syndrome (DS) are two relevant long-term adverse events after Roux-en-Y Gastric Bypass (RYGB) related to the dilation of the gastro-jejunal anastomosis. Transoral outlet reduction (TORe) is a minimally invasive and repeatable endoscopic procedure that was introduced to treat these conditions when medical treatment fails. In this case series, we evaluate the technical feasibility and short and medium-term outcomes of re-TORe in patients with weight regain and/or DS recurrence after primary TORe. Methods A retrospective analysis was done on a prospective database including patients that underwent TORe between January 2015 and October 2021; patients who received a re-TORe because of progressive loss of satiety and weight regain (≥50% of weight loss after primary TORe), or recurrence of DS were included in the analysis. DS recurrence was defined as Sigstad’s dumping score ≥7. Sigstad’s score, early and late Arts Dumping Score questionnaires, and %TBWL were assessed at baseline, at 6 and 12 months after re-TORe. Results Of 92 patients that underwent TORe, 10 required a re-TORe (3 patients for weight regain alone, 7 for both DS recurrence and weight regain). The median time between the primary TORe and the re-TORe was 28 months (range 14-64 years). Re-TORe was technically feasible in all patients. No periprocedural adverse events occurred. Re-TORe outcomes are summarized in ([Table 1]). Conclusions Re-TORe is technically feasible and has good short and medium-term outcomes in terms of weight loss and DS control. As such, repeating the procedure should be considered before referring patients for revision surgery. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S265-S266
Redo Transoral Outlet Reduction (Re-TORe): technical feasibility and medium-term outcomes
Aims Weight regain and dumping syndrome (DS) are two relevant long-term adverse events after Roux-en-Y Gastric Bypass (RYGB) related to the dilation of the gastro-jejunal anastomosis. Transoral outlet reduction (TORe) is a minimally invasive and repeatable endoscopic procedure that was introduced to treat these conditions when medical treatment fails. In this case series, we evaluate the technical feasibility and short and medium-term outcomes of re-TORe in patients with weight regain and/or DS recurrence after primary TORe. Methods A retrospective analysis was done on a prospective database including patients that underwent TORe between January 2015 and October 2021; patients who received a re-TORe because of progressive loss of satiety and weight regain (≥50% of weight loss after primary TORe), or recurrence of DS were included in the analysis. DS recurrence was defined as Sigstad’s dumping score ≥7. Sigstad’s score, early and late Arts Dumping Score questionnaires, and %TBWL were assessed at baseline, at 6 and 12 months after re-TORe. Results Of 92 patients that underwent TORe, 10 required a re-TORe (3 patients for weight regain alone, 7 for both DS recurrence and weight regain). The median time between the primary TORe and the re-TORe was 28 months (range 14-64 years). Re-TORe was technically feasible in all patients. No periprocedural adverse events occurred. Re-TORe outcomes are summarized in ([Table 1]). Conclusions Re-TORe is technically feasible and has good short and medium-term outcomes in terms of weight loss and DS control. As such, repeating the procedure should be considered before referring patients for revision surgery. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S317-S318
Women in menopause are not so disadvantaged: outcome of Endoscopic Sleeve Gastroplasty based on fertility status
Aims Endoscopic sleeve gastroplasty (ESG) is a safe and effective procedure in class 1 and 2 obese subjects.The effects of menopause on weight are well known. However, given that this patient population is inherently weight-concerned, understanding the effects of ESG on women in menopause is essential to guiding clinicians in counselling this patient population. Methods A prospective dataset collecting data on all ESG procedures performed in a tertiary referral centre was assessed retrospectively. Data on fertility status (menopause and non-menopause women) were collected. A comparison was performed using the Mann-Whitney U test. Results Between May 2017 and October 2021, 209 women underwent ESG. Out of the total, fertility status was available for 204 women: 79 menopause (38,7%), and 125 non-menopause women. At baseline, non-menopause women were younger, whereas there were no differences in BMI and weight. Six months after the procedure, non-menopause women showed significantly higher TBWL, WL and BAROS score compared to the menopausal group. Average TBWL, WL and EWL were not significantly different between the groups at 12 and 24 months (as shown in Table 1). Seven menopausal women needed revision procedures (5 Re-ESG, 1 Surgery), whereas ten non-menopausal women underwent revision (8 Re-ESG, two surgery). Conclusions Non-menopausal women who undergo ESG show better outcomes in the short term. However, this advantage does not persist in the medium and long term ([Table 1]). Weight loss trajectories of subjects who underwent Endoscopic Sleeve Gastroplasty, based on menopausal status. Data arereported as median (Interquartile range). Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S317-S318
Women in menopause are not so disadvantaged: outcome of Endoscopic Sleeve Gastroplasty based on fertility status
Aims Endoscopic sleeve gastroplasty (ESG) is a safe and effective procedure in class 1 and 2 obese subjects.The effects of menopause on weight are well known. However, given that this patient population is inherently weight-concerned, understanding the effects of ESG on women in menopause is essential to guiding clinicians in counselling this patient population. Methods A prospective dataset collecting data on all ESG procedures performed in a tertiary referral centre was assessed retrospectively. Data on fertility status (menopause and non-menopause women) were collected. A comparison was performed using the Mann-Whitney U test. Results Between May 2017 and October 2021, 209 women underwent ESG. Out of the total, fertility status was available for 204 women: 79 menopause (38,7%), and 125 non-menopause women. At baseline, non-menopause women were younger, whereas there were no differences in BMI and weight. Six months after the procedure, non-menopause women showed significantly higher TBWL, WL and BAROS score compared to the menopausal group. Average TBWL, WL and EWL were not significantly different between the groups at 12 and 24 months (as shown in Table 1). Seven menopausal women needed revision procedures (5 Re-ESG, 1 Surgery), whereas ten non-menopausal women underwent revision (8 Re-ESG, two surgery). Conclusions Non-menopausal women who undergo ESG show better outcomes in the short term. However, this advantage does not persist in the medium and long term ([Table 1]). Weight loss trajectories of subjects who underwent Endoscopic Sleeve Gastroplasty, based on menopausal status. Data arereported as median (Interquartile range). Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany